Department of Urology Division of Health Services Research University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA.
Department of Urology Division of Health Services Research University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA.
Urol Oncol. 2024 Dec;42(12):449.e13-449.e19. doi: 10.1016/j.urolonc.2024.06.011. Epub 2024 Aug 16.
Radical cystectomy readmission rates remain high, with around 25% of patients readmitted to index and nonindex hospitals in 30 days. Nonindex readmissions have been associated with poorer outcomes, including longer lengths of stay and higher mortality rates. This study aimed to examine the associations of social factors (e.g., sex, race, socioeconomic status, insurance type, and resident location) on readmission to index versus nonindex hospitals and discharge disposition.
We conducted a population-based retrospective study using the Pennsylvania Cancer Registry (PCR) to identify patients diagnosed with nonmetastatic muscle-invasive bladder cancer who underwent radical cystectomy in Pennsylvania between 2010 and 2018. Readmitted patients were identified using the Pennsylvania Health Care Cost Containment Council data (PHC4). The primary outcome was readmission location (i.e., index or nonindex hospital) following radical cystectomy. We used chi-square tests for categorical variables, Wilcoxon rank sum test for continuous variables, multivariable logistic regression model to assess predictors of being readmitted to an index hospital and calculating the predicted probability of being admitted to an index hospital depending on discharge disposition.
A total of 517 patients were readmitted within 30-days after radical cystectomy. The majority of readmissions were index readmissions (83%). Median readmission hospital stay was 4 days (interquartile range [IQR] 4) for index and 5 days (IQR 7) for nonindex hospitals, P = 0.01. Patients readmitted to index hospitals had fewer comorbidities (median weighted Elixhauser Comorbidity Index 2 (IQR 2)) and lived in urban areas (89%). Discharge with home care was associated with a higher odds of index readmission (odds ratio, [OR] 2.40; 95% confidence interval, [CI] 1.25-4.52).
Patients residing in urban areas and with fewer comorbidities were more likely to be readmitted to index hospitals than nonindex hospitals. Socioeconomic status and insurance type did not correlate with the type of readmission. Finally, being discharged with home health care was found to be a predictor of readmission to an index hospital.
根治性膀胱切除术的再入院率仍然很高,约有 25%的患者在 30 天内再次入住索引和非索引医院。非索引再入院与较差的预后相关,包括住院时间延长和死亡率升高。本研究旨在探讨社会因素(如性别、种族、社会经济地位、保险类型和居民所在地)与索引与非索引医院再入院和出院处置的关系。
我们使用宾夕法尼亚州癌症登记处(PCR)进行了一项基于人群的回顾性研究,以确定 2010 年至 2018 年间在宾夕法尼亚州接受根治性膀胱切除术的非转移性肌层浸润性膀胱癌患者。使用宾夕法尼亚州医疗保健成本控制委员会(PHC4)的数据来识别再入院患者。主要结局是根治性膀胱切除术后的再入院地点(即索引或非索引医院)。我们使用卡方检验进行分类变量分析,Wilcoxon 秩和检验进行连续变量分析,多变量逻辑回归模型评估被索引医院再入院的预测因素,并根据出院处置计算被索引医院入院的预测概率。
共有 517 例患者在根治性膀胱切除术后 30 天内再次入院。大多数再入院为索引再入院(83%)。索引再入院的中位住院时间为 4 天(四分位间距[IQR] 4),而非索引再入院的中位住院时间为 5 天(IQR 7),P=0.01。索引医院再入院的患者合并症较少(加权 Elixhauser 合并症指数中位数[IQR] 2),且居住在城市地区(89%)。出院后接受家庭护理与索引再入院的几率更高相关(优势比[OR] 2.40;95%置信区间[CI] 1.25-4.52)。
居住在城市地区、合并症较少的患者更有可能被再次收入索引医院,而非非索引医院。社会经济地位和保险类型与再入院类型无关。最后,发现出院后接受家庭健康护理是索引医院再入院的预测因素。